An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer.
10.1097/CM9.0000000000002862
- Author:
Cong LI
1
;
Fengzhu GUO
2
;
Jingtong ZHAI
1
;
Xiaohan LIU
3
;
Zhijun LI
1
;
Binghe XU
1
Author Information
1. Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
2. Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
3. Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, Liaoning 110122, China.
- Publication Type:Journal Article
- MeSH:
Immunogenic Cell Death;
Prognosis;
Immunotherapy;
Neoplasms
- From:
Chinese Medical Journal
2024;137(4):487-489
- CountryChina
- Language:English
